Chinese biotech firm Vcanbio Cell & Gene Engineering Corporation has led a series B round in Genetron Health, a Beijing-based cancer genomics solutions start-up.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
